The Bionic Pancreas Research Group has published clinical trial results from patients with type 1 diabetes (T1D). Patients between the ages of six and 79 years were randomised to either the bionic pancreas (n=219) with insulin aspart, or insulin lispro, or standard of care (SOC) (n=107).

The primary outcome of glycated...